Emerging therapeutics in idiopathic inflammatory myopathy
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic autoimmune diseases characterized mainly by inflammation of muscle tissue. Although IIM traditionally encompasses polymyositis, dermatomyositis (DM), and inclusion body myositis, the disease concept has been changing in...
Saved in:
| Main Author: | Shinji Sato |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-01-01
|
| Series: | Indian Journal of Rheumatology |
| Subjects: | |
| Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=6;spage=153;epage=162;aulast=Sato |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammatory myopathies: an update for neurologists
by: André Macedo Serafim Silva, et al.
Published: (2022-08-01) -
Juvenile dermatomyositis: Controversies and recent developments in management
by: Himanshi Chaudhary, et al.
Published: (2020-01-01) -
Role of myositis-specific autoantibodies in personalized therapy
by: Anand N Malaviya, et al.
Published: (2018-01-01) -
Multisystemic Complications and Rapid Decline in Anti‐MDA‐5 Positive Amyopathic Dermatomyositis: A Case Study
by: Hem Prajapati, et al.
Published: (2025-03-01) -
Pathogenesis of muscle weakness in inflammatory myositis
by: Sai Kumar Dunga, et al.
Published: (2020-01-01)